Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Country:  U.S.A.
Treatment/Intervention:  CAM pharmacological or biological treatment
Results 1-1 of 1 for your search:
Start Over
Basiliximab in Treating Patients with Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia
Phase: Phase I
Type: Diagnostic, Treatment
Age: 18 and over
Trial IDs: Pro00000581, NCI-2011-03848, CDR0000579683, SPORE Project 3, DUMC-PRO00000581, NCT00626483
Start Over